119 related articles for article (PubMed ID: 15723589)
1. Cytogenetic testing for therapeutic indication in cancer.
Mundle S; Noskina Y
Expert Rev Mol Diagn; 2005 Jan; 5(1):23-9. PubMed ID: 15723589
[TBL] [Abstract][Full Text] [Related]
2. Proposals for standardized protocols for cytogenetic analyses of acute leukemias, chronic lymphocytic leukemia, chronic myeloid leukemia, chronic myeloproliferative disorders, and myelodysplastic syndromes.
Haferlach C; Rieder H; Lillington DM; Dastugue N; Hagemeijer A; Harbott J; Stilgenbauer S; Knuutila S; Johansson B; Fonatsch C
Genes Chromosomes Cancer; 2007 May; 46(5):494-9. PubMed ID: 17311250
[TBL] [Abstract][Full Text] [Related]
3. [Pathogenesis, pathophysiology and treatment of chronic lymphocytic leukemia].
Suzumiya J; Inoue M; Kumanomido S
Nihon Rinsho; 2012 Apr; 70 Suppl 2():470-5. PubMed ID: 23134001
[No Abstract] [Full Text] [Related]
4. Synchronous occurrence of Philadelphia chromosome-positive chronic myelogenous leukemia and breast cancer.
Tillawi IS
Saudi Med J; 2007 Feb; 28(2):291-4. PubMed ID: 17268717
[No Abstract] [Full Text] [Related]
5. New insights into the pathobiology and treatment of chronic myelogenous leukemia.
Cotta CV; Bueso-Ramos CE
Ann Diagn Pathol; 2007 Feb; 11(1):68-78. PubMed ID: 17240312
[TBL] [Abstract][Full Text] [Related]
6. Co-occurrence of chronic myeloid leukemia with chronic lymphocytic leukemia: a report of two cases.
Boddu P; Gibbons J; Burger J; Sivina M; Thakral B; Kanagal-Shamanna R; Ferrajoli A
Leuk Lymphoma; 2019 Jun; 60(6):1568-1571. PubMed ID: 30632839
[No Abstract] [Full Text] [Related]
7. Concomitant chronic myeloid leukemia and chronic lymphocytic leukemia: a different clonal origin shown by molecular cytogenetics.
Gozzetti A; Bocchia M; Crupi R; Calabrese S; Pirrotta MT; Raspadori D; Defina M; Algeri R; Lauria F
Cancer Genet Cytogenet; 2008 Jan; 180(1):83-4. PubMed ID: 18068541
[No Abstract] [Full Text] [Related]
8. Chronic lymphocytic leukemia developing in a patient with chronic myeloid leukemia: evidence of distinct lineage-associated genomic events.
Gargallo P; Cacchione R; Chena C; Dupont J; Garay G; Riveros D; Larripa I; Slavutsky I
Cancer Genet Cytogenet; 2005 Aug; 161(1):74-7. PubMed ID: 16080961
[TBL] [Abstract][Full Text] [Related]
9. [New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia].
Matolcsy A
Orv Hetil; 2004 Dec; 145(52):2603-9. PubMed ID: 15724695
[TBL] [Abstract][Full Text] [Related]
10. Can morphological assessment limit the use of specific genetic testing to exclude chronic myeloid leukaemia?
So CC; Wan TS; Yip SF; Ma SK; Lam CC; Chan LC
Br J Haematol; 2007 May; 137(4):377. PubMed ID: 17374140
[No Abstract] [Full Text] [Related]
11. Impact of cytogenetic and molecular prognostic markers on the clinical management of chronic lymphocytic leukemia.
Hauswirth AW; Jäger U
Haematologica; 2008 Jan; 93(1):14-9. PubMed ID: 18166780
[No Abstract] [Full Text] [Related]
12. Leukaemias into the 21st century. Part 2: the chronic leukaemias.
Gibson J; Iland HJ; Larsen SR; Brown CM; Joshua DE
Intern Med J; 2013 May; 43(5):484-94. PubMed ID: 23668266
[TBL] [Abstract][Full Text] [Related]
13. Chronic myeloid leukemia and chronic lymphocytic leukemia.
Gore JM
JAAPA; 2014 Feb; 27(2):45-6; quiz 45-6. PubMed ID: 24463751
[No Abstract] [Full Text] [Related]
14. Prognostic impact of chromosome alterations detected by FISH in Turkish patients with B-cell chronic lymphocytic leukemia.
Durak B; Akay OM; Aslan V; Ozdemir M; Sahin F; Artan S; Gülbas Z
Cancer Genet Cytogenet; 2009 Jan; 188(2):65-9. PubMed ID: 19100507
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic role of conventional cytogenetics and fluorescence in situ hybridization (FISH) in chronic myeloid leukemia patients.
Jha CB; Kucheria K; Choudhary VP
Kathmandu Univ Med J (KUMJ); 2006; 4(2):171-5. PubMed ID: 18603893
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetics in the management of "chronic myeloid leukemia": an update by the Groupe francophone de cytogénétique hématologique (GFCH).
Roche-Lestienne C; Boudry-Labis E; Mozziconacci MJ
Ann Biol Clin (Paris); 2016 Oct; 74(5):511-515. PubMed ID: 27477825
[TBL] [Abstract][Full Text] [Related]
17. Is there an entity of chemically induced BCR-ABL-positive chronic myelogenous leukemia?
Lichtman MA
Oncologist; 2008 Jun; 13(6):645-54. PubMed ID: 18586919
[TBL] [Abstract][Full Text] [Related]
18. Clonal cytogenetic abnormalities in patients with chronic myeloid leukemia in complete cytogenetic response to imatinib mesylate.
Espinet B; Oliveira AC; Boqué C; Domingo A; Alonso E; Solé F
Haematologica; 2005 Apr; 90(4):556-8. PubMed ID: 15820956
[TBL] [Abstract][Full Text] [Related]
19. Molecular cytogenetic characterization of deletions on der(9) in chronic myelocytic leukemia.
Zagaria A; Anelli L; Albano F; Vicari L; Schiavone EM; Annunziata M; Pane F; Liso V; Rocchi M; Specchia G
Cancer Genet Cytogenet; 2006 Jun; 167(2):97-102. PubMed ID: 16737907
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetic and molecular responses and outcome in chronic myelogenous leukemia: need for new response definitions?
Kantarjian H; O'Brien S; Shan J; Huang X; Garcia-Manero G; Faderl S; Ravandi-Kashani F; Verstovsek S; Beth Rios M; Cortes J
Cancer; 2008 Feb; 112(4):837-45. PubMed ID: 18085610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
